This trial compares the quality of life, toxicity, and disease control of men with prostate cancer treated with proton therapy vs. IMRT.
2 Primary · 3 Secondary · Reporting Duration: 3-years after the end of radiation therapy
Active Control
Experimental Treatment
3000 Total Participants · 4 Treatment Groups
Primary Treatment: Proton Arm 1: Standard Proton Therapy · No Placebo Group · N/A
Age 30 - 85 · Male Participants · 8 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: